LLBO OTC
Lifeline Biotechnologies, Inc.
1W: +0.0%
1M: -20.0%
3M: -42.9%
YTD: -42.9%
1Y: -60.0%
3Y: +100.0%
5Y: -83.3%
$0.00
+0.00 (+33.33%)
Weekly Expected Move ±90.0%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$441K
+0.0% ▲
3Y CAGR: +28.6%
Total Liabilities
$386K
+0.0% ▲
3Y CAGR: +2.7%
Shareholders Equity
$55K
+0.0% ▲
Cash & Investments
$415
+0.0% ▲
3Y CAGR: -18.0%
Total Debt
$327K
+0.0% ▲
3Y CAGR: -0.1%
Net Debt
$327K
+0.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|
| — Assets — | ||||
| Cash | $753 | $5K | $345 | $415 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $753 | $5K | $345 | $415 |
| Net Receivables | $0 | $0 | $188K | $175K |
| Inventory | $1K | $1K | $1K | $1K |
| Other Current Assets | $0 | $0 | $0 | $0 |
| Total Current Assets | $2K | $6K | $191K | $178K |
| Property, Plant & Equip. | $0 | $0 | $0 | $0 |
| Goodwill & Intangibles | $38K | $35K | $0 | $0 |
| Long-Term Investments | $166K | $271K | $312K | $262K |
| Other Non-Current Assets | $1K | $1K | $1K | $1K |
| Total Non-Current Assets | $205K | $308K | $313K | $263K |
| Total Assets | $207K | $314K | $503K | $441K |
| — Liabilities — | ||||
| Accounts Payable | $28K | $24K | $21K | $59K |
| Short-Term Debt | $328K | $433K | $384K | $327K |
| Deferred Revenue | $0 | -$0 | $0 | $0 |
| Other Current Liabilities | -$0 | $0 | $0 | -$0 |
| Total Current Liabilities | $356K | $457K | $405K | $386K |
| Long-Term Debt | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 |
| Total Liabilities | $356K | $457K | $405K | $386K |
| — Equity — | ||||
| Common Stock | $31K | $31K | $31K | $31K |
| Retained Earnings | -$14M | -$14M | -$14M | -$14M |
| Accumulated OCI | $14M | $14M | $14M | $14M |
| Total Stockholders Equity | -$149K | -$143K | $99K | $55K |
| Total Liabilities & Equity | $207K | $314K | $503K | $441K |
| — Key Metrics — | ||||
| Total Debt | $328K | $433K | $384K | $327K |
| Net Debt | $328K | $428K | $383K | $327K |
| Total Investments | $166K | $271K | $312K | $262K |